Masimo MASI announced today that findings from a new study published in the American Journal of Surgery demonstrate that noninvasive and continuous hemoglobin monitoring correlates strongly with invasive laboratory hemoglobin testing and "can be beneficial in the operating room and critical care setting and may potentially decrease the invasiveness of both elective surgery and critical illness."
This is the first study to examine the accuracy and reliability of Masimo SpHb for measuring hemoglobin and hemorrhage in both the operating room and intensive care unit.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in